SG11201806091YA - Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulation - Google Patents
Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulationInfo
- Publication number
- SG11201806091YA SG11201806091YA SG11201806091YA SG11201806091YA SG11201806091YA SG 11201806091Y A SG11201806091Y A SG 11201806091YA SG 11201806091Y A SG11201806091Y A SG 11201806091YA SG 11201806091Y A SG11201806091Y A SG 11201806091YA SG 11201806091Y A SG11201806091Y A SG 11201806091YA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- rule
- new york
- formulation
- new jersey
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/002—Compounding apparatus specially for enteral or parenteral nutritive solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/04—Heat
- A61L2/06—Hot gas
- A61L2/07—Steam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/10—Apparatus features
- A61L2202/18—Aseptic storing means
- A61L2202/181—Flexible packaging means, e.g. permeable membranes, paper
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/21—Pharmaceuticals, e.g. medicaments, artificial body parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/23—Containers, e.g. vials, bottles, syringes, mail
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662291589P | 2016-02-05 | 2016-02-05 | |
| PCT/IB2017/050341 WO2017134540A1 (en) | 2016-02-05 | 2017-01-23 | Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201806091YA true SG11201806091YA (en) | 2018-08-30 |
Family
ID=57915030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201806091YA SG11201806091YA (en) | 2016-02-05 | 2017-01-23 | Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulation |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20190029979A1 (pt) |
| EP (1) | EP3411004B1 (pt) |
| JP (1) | JP2019506407A (pt) |
| KR (1) | KR102246136B1 (pt) |
| CN (1) | CN108601704A (pt) |
| AU (2) | AU2017215419B2 (pt) |
| BR (1) | BR112018014354A2 (pt) |
| CA (1) | CA3013413C (pt) |
| CY (1) | CY1124008T1 (pt) |
| DK (1) | DK3411004T3 (pt) |
| ES (1) | ES2867392T3 (pt) |
| HU (1) | HUE053952T4 (pt) |
| IL (1) | IL260320B (pt) |
| MX (1) | MX2018009497A (pt) |
| PL (1) | PL3411004T3 (pt) |
| PT (1) | PT3411004T (pt) |
| RU (1) | RU2729528C2 (pt) |
| SG (1) | SG11201806091YA (pt) |
| SI (1) | SI3411004T1 (pt) |
| WO (1) | WO2017134540A1 (pt) |
| ZA (1) | ZA201804970B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10052296B2 (en) | 2016-04-07 | 2018-08-21 | Nevakar Inc. | Formulations for treating pain |
| WO2019070641A1 (en) * | 2017-10-03 | 2019-04-11 | Nevakar Inc. | COMBINATIONS OF ACETAMINOPHENE-PRÉGABALINE AND METHODS OF TREATING PAIN |
| JP7512762B2 (ja) | 2020-08-20 | 2024-07-09 | ニプロ株式会社 | スガマデクス含有の液体製剤 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5314405A (en) * | 1992-04-17 | 1994-05-24 | Science Incorporated | Liquid delivery apparatus |
| FR2751875B1 (fr) | 1996-08-05 | 1998-12-24 | Scr Newpharm | Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation |
| FR2809619B1 (fr) | 2000-06-06 | 2004-09-24 | Pharmatop | Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention |
| JP4929352B2 (ja) * | 2006-07-18 | 2012-05-09 | スペイン ファルマ ソシエダ アノニマ | 注入可能なパラセタモール液剤 |
| CN101522223A (zh) * | 2006-07-20 | 2009-09-02 | 西科尔公司 | 固体无菌活性药物成分的制备方法 |
| RU2010110393A (ru) * | 2010-03-18 | 2011-09-27 | Биотекуе Корпоратион (CN) | Экологически безопасный мягкий пакет для инфузионного раствора |
| PT2377516E (pt) * | 2010-04-14 | 2012-07-02 | Braun Melsungen Ag | Composição acetaminofeno |
| DE202011102490U1 (de) * | 2011-04-07 | 2012-06-28 | Klosterfrau Berlin Gmbh | Sterilisation von medizinischen Instrumenten für die Injektion und/oder Instillation |
| IN2014DN09993A (pt) * | 2012-05-09 | 2015-08-14 | Icrom Spa | |
| ZA201300398B (en) * | 2012-11-27 | 2013-09-25 | Genfarma Laboratories S L | Injectable liquid formulation of the combination of tramadol and paracetamol |
| US8835505B1 (en) * | 2013-03-15 | 2014-09-16 | Welgrace Research Group | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
| US20140303254A1 (en) * | 2013-04-08 | 2014-10-09 | InnoPharma Licensing LLC | Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation |
| ES2837949T3 (es) * | 2014-07-25 | 2021-07-01 | Terumo Corp | Preparación de solución de inyección de acetaminofén envasada |
-
2017
- 2017-01-23 ES ES17702164T patent/ES2867392T3/es active Active
- 2017-01-23 BR BR112018014354A patent/BR112018014354A2/pt active Search and Examination
- 2017-01-23 EP EP17702164.9A patent/EP3411004B1/en active Active
- 2017-01-23 PL PL17702164T patent/PL3411004T3/pl unknown
- 2017-01-23 SI SI201730757T patent/SI3411004T1/sl unknown
- 2017-01-23 CA CA3013413A patent/CA3013413C/en active Active
- 2017-01-23 MX MX2018009497A patent/MX2018009497A/es unknown
- 2017-01-23 JP JP2018539952A patent/JP2019506407A/ja active Pending
- 2017-01-23 WO PCT/IB2017/050341 patent/WO2017134540A1/en active Application Filing
- 2017-01-23 RU RU2018128397A patent/RU2729528C2/ru active
- 2017-01-23 US US16/075,745 patent/US20190029979A1/en not_active Abandoned
- 2017-01-23 PT PT177021649T patent/PT3411004T/pt unknown
- 2017-01-23 CN CN201780007917.6A patent/CN108601704A/zh active Pending
- 2017-01-23 SG SG11201806091YA patent/SG11201806091YA/en unknown
- 2017-01-23 HU HUE17702164A patent/HUE053952T4/hu unknown
- 2017-01-23 KR KR1020187022364A patent/KR102246136B1/ko active IP Right Grant
- 2017-01-23 AU AU2017215419A patent/AU2017215419B2/en not_active Ceased
- 2017-01-23 DK DK17702164.9T patent/DK3411004T3/da active
-
2018
- 2018-06-27 IL IL260320A patent/IL260320B/en unknown
- 2018-07-24 ZA ZA2018/04970A patent/ZA201804970B/en unknown
-
2019
- 2019-10-31 AU AU2019257508A patent/AU2019257508B2/en not_active Ceased
-
2020
- 2020-06-30 US US16/917,089 patent/US20200330411A1/en not_active Abandoned
-
2021
- 2021-04-08 CY CY20211100304T patent/CY1124008T1/el unknown
- 2021-10-07 US US17/496,276 patent/US20220023238A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3411004A1 (en) | 2018-12-12 |
| PT3411004T (pt) | 2021-05-11 |
| KR102246136B1 (ko) | 2021-04-29 |
| JP2019506407A (ja) | 2019-03-07 |
| AU2019257508A1 (en) | 2019-11-21 |
| AU2019257508B2 (en) | 2020-12-24 |
| SI3411004T1 (sl) | 2021-08-31 |
| IL260320A (en) | 2018-08-30 |
| RU2018128397A (ru) | 2020-03-05 |
| RU2018128397A3 (pt) | 2020-03-05 |
| AU2017215419A1 (en) | 2018-07-19 |
| US20220023238A1 (en) | 2022-01-27 |
| BR112018014354A2 (pt) | 2018-12-18 |
| HUE053952T4 (hu) | 2021-09-28 |
| IL260320B (en) | 2021-10-31 |
| EP3411004B1 (en) | 2021-03-10 |
| ES2867392T3 (es) | 2021-10-20 |
| RU2729528C2 (ru) | 2020-08-07 |
| WO2017134540A1 (en) | 2017-08-10 |
| CY1124008T1 (el) | 2022-05-27 |
| US20190029979A1 (en) | 2019-01-31 |
| HUE053952T2 (hu) | 2021-08-30 |
| MX2018009497A (es) | 2019-05-06 |
| CA3013413C (en) | 2020-12-01 |
| US20200330411A1 (en) | 2020-10-22 |
| AU2017215419B2 (en) | 2019-11-21 |
| KR20180100615A (ko) | 2018-09-11 |
| CN108601704A (zh) | 2018-09-28 |
| DK3411004T3 (da) | 2021-04-19 |
| PL3411004T3 (pl) | 2021-10-18 |
| CA3013413A1 (en) | 2017-08-10 |
| ZA201804970B (en) | 2019-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201809912UA (en) | Hybrid carriers for nucleic acid cargo | |
| SG11201810116VA (en) | Exosomes comprising therapeutic polypeptides | |
| SG11201908740VA (en) | Sustained release delivery systems comprising traceless linkers | |
| SG11201908670SA (en) | Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators | |
| SG11201900344YA (en) | Treatment and prevention of cytokine release syndrome using a chimeric antigen receptor in combination with a kinase inhibitor | |
| SG11201408174UA (en) | Antibody formulation | |
| SG11201804577RA (en) | Fgf21 variants | |
| SG11201810485SA (en) | Substituted carbonucleoside derivatives useful as anticancer agents | |
| SG11201810628XA (en) | Nasal pharmaceutical compositions with a porous excipient | |
| SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| SG11201804263PA (en) | Cancer treatment using 2-deoxy-2-fluoro-l-fucose in combination with a checkpoint inhibitor | |
| SG11201900443VA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
| SG11201811712QA (en) | 5,7-dihydro-pyrrolo-pyridine derivatives for treating neurological and neurodegenerative diseases | |
| SG11201903326RA (en) | Liposomal formulation for use in the treatment of cancer | |
| SG11201901986SA (en) | Process for the manufacture of a solid pharmaceutical adminstration form | |
| SG11201900546UA (en) | Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201408511QA (en) | Liquid preparations of amines and organic acids stabilized by salts | |
| SG11201803949RA (en) | Novel pharmaceutical composition comprising particles comprising a complex of a double-stranded polyribonucleotide and a polyalkyleneimine | |
| SG11201811221XA (en) | Imidazo[1,2-a]pyridine derivatives, methods for preparing the same and use thereof | |
| SG11201805755SA (en) | Methods of administering hepcidin | |
| SG11201810940XA (en) | Methods of treating pancreatic cancer | |
| SG11201901048VA (en) | Pharmaceutical compositions and uses directed to lysosomal storage disorders | |
| SG11201909735YA (en) | Therapeutic compounds and compositions, and methods of use thereof | |
| SG11201806091YA (en) | Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulation |